Treatment Overview: Hereditary Transthyretin Amyloidosis
We live in a time of rapid advances in genetic know-how
and pharmacological technologies. The pace of discovery is accelerating, driving the development of new therapies, with 3 newly approved treatments. The exact course of hATTR varies with each patient, but the outlook holds promise for all. This booklet is designed as a comprehensive guide to help you and your family navigate treatment resources and options that would be most effective for you.
- Resource Categories